Clinical Trial Update: Specialized Pacing for Patients With Congenital Heart Disease [Phase 2, Phase 3]

View source ↗

Summary

A Clinical Trial Update notes termination for a specialized pacing study in congenital heart disease and bradycardia, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia
• Congenital Heart Disease

Snippet

Sponsor: University of California, Los Angeles | Conditions: Congenital Heart Disease, Bradycardia Sinus | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2023-01-20